<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: The impact of lipometabolic and glucometabolic disturbances on <z:hpo ids='HP_0001297'>stroke</z:hpo> incidence remains to be characterized in detail </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated relations of a comprehensive panel of baseline lipometabolic and glucometabolic variables to incident fatal and nonfatal <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>), and <z:hpo ids='HP_0001297'>stroke</z:hpo> subtypes </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A community-based prospective study of 2313 middle-aged men invited to a health survey at age 50 </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: During a follow-up of up to 32 years, 421 developed <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:hpo ids='HP_0002326'>TIA</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In Cox proportional hazards analyses adjusting for treatment with <z:chebi fb="1" ids="35554">cardiovascular drugs</z:chebi> at baseline, 1-standard deviation increases in body mass index, systolic and diastolic blood pressures, serum proinsulin, and <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) were associated with 11 to 35% increased risk for subsequent <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>TIA</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Electrocardiographic <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo> and smoking were also associated with a higher risk for <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>TIA</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Essentially the same variables were related to <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>/<z:hpo ids='HP_0002326'>TIA</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Higher proportions of palmitic (16:0), palmitoleic (16:1), and <z:chebi fb="0" ids="16196">oleic acid</z:chebi> (18:1) in <z:chebi fb="0" ids="17002">cholesterol esters</z:chebi> were associated with an increased risk, whereas a higher proportion of <z:chebi fb="0" ids="17351">linoleic acid</z:chebi> (18:2 n-6) was protective against <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>TIA</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Further adjusting <z:hpo ids='HP_0000001'>all</z:hpo> models also for <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp>, the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, serum cholesterol, <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo>, <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, smoking, and physical activity, essentially the same pattern was observed </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Indices of an unhealthy dietary fat intake and a high serum <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a) level predicted fatal and nonfatal <z:hpo ids='HP_0001297'>stroke</z:hpo>/<z:hpo ids='HP_0002326'>TIA</z:hpo> independently of established risk factors in a community-based sample of middle-aged men followed for 32 years </plain></SENT>
</text></document>